Skip to main content
Be The InvestorBe The Investor logo
BTI Market Newsearnings
Back to News

Merck's Newer Medicines Are Growing, but Gardasil Still Matters

Merck's Newer Medicines Are Growing, but Gardasil Still Matters

Merck's Winrevair and Capvaxive are expanding rapidly as Lipfendra joins the pipeline, yet Gardasil still generated $1.2 billion in the second quarter. Diversification is improving, not complete.

Merck is building a broader growth story around newer medicines, but its vaccine franchise has not become irrelevant. In the second quarter of 2026, Gardasil generated $1.2 billion in sales, still more than either Winrevair or Capvaxive despite the company's increasing emphasis on recent launches.

The latest official results show why management's message has shifted. Winrevair, a treatment for pulmonary arterial hypertension, produced $588 million of second-quarter sales, up 75% from a year earlier. Capvaxive, Merck's pneumococcal vaccine, generated $184 million, up 40%. The Food and Drug Administration also approved Lipfendra in July as the first once-daily oral PCSK9 inhibitor for reducing LDL cholesterol in eligible adults.

Those figures correct a timing problem in the source comparison. The $525 million Winrevair and $142 million Capvaxive numbers cited there were first-quarter results, not second-quarter sales. Comparing periods consistently matters because the diversification thesis depends on the pace of adoption.

Gardasil's second-quarter sales rose 3% excluding currency effects after severe weakness in China had weighed on prior periods. That is an improvement, but it does not remove geographic and channel risk. Merck still needs newer products to grow quickly enough to offset volatility in Gardasil and the eventual loss of exclusivity for Keytruda, its dominant cancer medicine.

Pipeline progress provides support, not certainty. Positive late-stage results and new approvals can widen the revenue base, but launches also require reimbursement, physician adoption and commercial execution. Acquisition charges can further obscure near-term margins, as seen when Merck adjusted guidance after agreeing to buy Terns Pharmaceuticals.

The next quarterly report should be judged on consistent metrics: Gardasil's year-over-year trend, Winrevair and Capvaxive sequential growth, early Lipfendra launch indicators and any updated development timeline for oncology assets. Merck's story is becoming more diversified, but the numbers show the transition is still underway rather than complete.

That distinction keeps the investment case grounded in reported product sales rather than presentation emphasis alone.

Find us onGoogle News

Latest comments

BT
Community Guidelines

Related News

earnings20 / 10 / 2026

Mastercard’s Record Run Raises the Bar for October Earnings

Mastercard enters its October 29 report after strong second-quarter growth, leaving investors focused on cross-border volume, service revenue and whether margins can absorb continued investment.

earnings20 / 10 / 2026

FMC’s Guidance Collapse Signals a Channel Reset, Not a Normal Miss

FMC cut third-quarter revenue expectations to $65 million to $125 million and forecast a steep adjusted EBITDA loss as it discounts inventory and changes U.S. pricing.

earnings20 / 10 / 2026

RTX's Pratt Sales Rise 16% Even as New-Engine Mix Weighs on Growth

Pratt & Whitney's second-quarter sales rose 16%, but commercial original-equipment revenue fell as engine mix and repair demand redirected parts. RTX's next report should show whether service recovery and new deliveries can advance together.

earnings20 / 10 / 2026

Tesla, Meta and RTX Earnings Put AI Spending and Industrial Demand to the Test

A concentrated earnings calendar will test two market concerns at once: whether heavy AI spending is producing returns and whether industrial and consumer demand can withstand higher financing costs after a bruising week for technology shares.

earnings19 / 10 / 2026

American Airlines Faces a Narrower Margin for Error as Fuel Costs Surge

American Airlines’ revenue growth was overwhelmed by an 83% jump in fuel expense, pushing margins and earnings sharply lower. Premium demand and liquidity help, but the carrier’s outlook remains unusually wide.

earnings19 / 10 / 2026

Spotify's Buyback and Rogan Renewal Put Q3 Margins in Focus

Spotify renewed Joe Rogan and expanded its repurchase authorization by $1.5 billion ahead of third-quarter results. Subscriber growth and record gross margin support the case, but content costs and advertising remain key tests.

Next Article
earnings 19 / 10 / 2026 Be The Investor Research 2 min read

Morgan Stanley's $232 Billion Wealth Inflow Tests Its New Model

Share
Morgan Stanley's $232 Billion Wealth Inflow Tests Its New Model

Morgan Stanley's wealth unit posted record quarterly revenue and $232 billion of net new assets, but more than half of those flows were tied to IPO activity. The recurring-revenue strategy is working, with a cyclical caveat.

Morgan Stanley's wealth-management strategy delivered a record third quarter, but the quality of the quarter deserves a closer look. The division generated $9.1 billion of net revenue, up from $8.2 billion a year earlier, while net new assets reached $232 billion compared with $81 billion in the prior-year period.

More than half of the new assets were associated with initial public offerings. That does not make the inflow less real, but it means the quarter benefited from a channel that can fluctuate sharply with capital-market activity.

A larger pool of fee-producing assets

Loading market context

Morgan Stanley now oversees about $10.5 trillion across wealth and investment management. That asset base supports advisory, lending and other recurring revenue, reducing the firm's dependence on trading and investment banking.

The shift began after the 2008 financial crisis and continued through acquisitions and adviser expansion. It gives Morgan Stanley a different earnings mix from Goldman Sachs, which remains more exposed to whether deals close, and from Charles Schwab, whose results are particularly sensitive to client cash balances and interest rates.

The latest quarter also showed that the old engine still matters. Morgan Stanley reported $5.8 billion of equities trading revenue, up 41% from a year earlier. The firm is not abandoning trading. It is using wealth management to make the overall business less dependent on a single market cycle.

Where the moat can narrow

Asset-based fees rise when markets and client balances grow, but the same mechanism works in reverse during a selloff. A concentrated equity market adds another risk because falling prices among a small number of large technology holdings can reduce client assets quickly.

IPO-linked flows also complicate the comparison. Management said the active IPO calendar accelerates its funnel and deepens client relationships, yet those flows should not be extrapolated as a steady quarterly run rate. The better test is whether Morgan Stanley retains those assets and expands advice, lending and investment services around them.

The quarter validates the strategic direction without eliminating cyclicality. Wealth management has made Morgan Stanley more durable, but record flows arrived with favorable markets and unusually strong IPO activity. Investors should watch asset retention and the share of future inflows that comes from repeatable adviser-led channels rather than one-time liquidity events.

Find us onGoogle News

Latest comments

BT
Community Guidelines
Next Article
earnings 19 / 10 / 2026 Be The Investor Research 1 min read

GE Aerospace and RTX Earnings Must Clear Guidance Already Priced Higher

Share
GE Aerospace and RTX Earnings Must Clear Guidance Already Priced Higher

GE Aerospace and RTX report Tuesday after raising guidance last quarter. Consensus estimates already meet or exceed those ranges, so cash flow, aftermarket growth and production capacity may matter more than headline beats.

GE Aerospace and RTX enter third-quarter earnings with a demanding setup: both beat estimates and raised guidance last quarter, while analyst expectations already assume at least part of another improvement. The companies report before the opening bell on October 20.

GE Aerospace delivered second-quarter adjusted earnings of $2.02 a share, up 22%, as revenue increased 21%. The company raised full-year adjusted EPS guidance to $7.65 to $7.85 and free cash flow guidance to $8.9 billion to $9.2 billion. Consensus cited in the source article expects $7.92, already above the top of that range.

RTX reported second-quarter adjusted EPS of $1.89 and 16% organic sales growth, with $2.9 billion of free cash flow. It raised full-year adjusted EPS guidance to $7.10 to $7.25 and free cash flow guidance to $8.50 billion to $8.75 billion. Consensus of $7.25 reaches the high end of the EPS range.

Loading market context

The operating questions differ. GE's commercial services revenue rose 26% last quarter, making engine utilization and shop-visit demand central to the outlook. Investors also need evidence that supply-chain investments can translate demand into deliveries without absorbing too much cash.

RTX combines commercial aerospace with defense. Pratt & Whitney's aftermarket grew 25%, while Raytheon benefited from Patriot, Standard Missile and AMRAAM demand. Powder-metal inspections on geared turbofan engines, tariffs and production capacity remain the constraints.

The valuation test is therefore about guidance quality rather than one quarterly beat. If either company merely repeats its existing range, investors may read that as caution because consensus already embeds stronger earnings. Conversely, higher guidance backed by cash generation would be more persuasive than a revenue beat driven by timing.

The two reports will provide a useful cross-check on aircraft service demand, engine output and weapons production. Those operational indicators can reveal whether record backlogs are becoming revenue or remaining constrained by parts and factory capacity.

Find us onGoogle News

Latest comments

BT
Community Guidelines
Next Article
earnings 19 / 10 / 2026 Be The Investor Research 1 min read

Fifth Third’s Comerica Deal Starts to Show Operating Leverage

Share
Fifth Third’s Comerica Deal Starts to Show Operating Leverage

Fifth Third lifted third-quarter profit as Comerica integration boosted net interest income, while stable credit, stronger capital and locked-in expense savings supported the combined bank’s outlook.

Fifth Third Bancorp’s acquisition of Comerica is beginning to show up in earnings power, even though merger costs kept reported per-share profit nearly flat from a year earlier.

Net income available to common shareholders rose 36% year over year to $828 million in the third quarter. Diluted earnings per share slipped 1% to $0.90, while adjusted earnings per share were $1.13 after excluding $0.23 of merger and other items.

The underlying improvement came from both scale and integration. Net interest income rose 3% from the second quarter to $2.28 billion and increased 49% from a year earlier, largely because Comerica expanded the balance sheet. Adjusted pre-provision net revenue rose 8% sequentially, and the bank reported 450 basis points of positive operating leverage, meaning revenue grew faster than adjusted expenses.

Fifth Third completed the Comerica systems conversion during the quarter and said the full $850 million annual expense-synergy run rate was locked in for the fourth quarter. Management also reported strong client and banker retention, a key risk after large bank combinations.

Funding and credit metrics remained stable. Average deposits increased 3% sequentially to $238.3 billion, while the loan-to-core-deposit ratio improved to 76% from 77%. Net charge-offs were 0.31% of average portfolio loans, compared with 0.30% in the prior quarter, and the provision for credit losses fell to $122 million from $129 million.

Capital moved in the right direction as well. The common equity tier 1 ratio increased to 10.02% from 9.93%. That gives the combined bank more flexibility as it absorbs integration costs and manages a larger credit book.

The main caveat is that reported results still contain sizable deal noise. Fifth Third recorded $215 million of pretax merger costs, plus technology impairments and interchange-litigation expenses. Investors now need evidence that the promised savings persist after conversion work fades, without deterioration in deposits or credit. The quarter supports that case, but the next test is converting locked-in cost synergies into durable per-share growth.

Find us onGoogle News

Latest comments

BT
Community Guidelines
Next Article
earnings 19 / 10 / 2026 Be The Investor Research 2 min read

Capital One and Meta Earnings Will Put Spending Discipline on Trial

Share
Capital One and Meta Earnings Will Put Spending Discipline on Trial

Capital One and Meta enter earnings with different businesses but a shared investor concern: heavy investment. The key is whether spending produces durable growth without overwhelming near-term profit and cash flow.

Capital One and Meta report earnings on consecutive evenings with a common investor concern: both are spending heavily now in pursuit of future advantages.

Capital One reports after Tuesday's close. The bank and card issuer has been investing in technology, integration and business growth, while its shares were down more than 16% for the year in the original report. Investors will want to know how much of that spending continues and when management expects it to support stronger earnings.

The important measures extend beyond one quarter's net income. Credit-card delinquencies and charge-offs show how borrowers are performing. Net interest margin shows how effectively Capital One earns the spread between asset yields and funding costs. Operating expense and integration targets indicate whether investment is becoming permanent overhead or creating future efficiency.

Loading market context

Meta reports after Wednesday's close. Its new Muse personal AI agent had drawn strong early attention, according to CNBC, but expanding the service may require additional data-center capacity and product spending. The stock rose after the September 8 launch and later cooled as investors considered the cost.

Meta's central test is whether AI investment strengthens its advertising engine, user engagement or new paid products. Capital expenditure by itself does not establish value. Investors need evidence that incremental computing capacity supports measurable revenue or operating gains.

For both companies, the useful question is not whether investment rises, but whether each dollar creates enough growth or efficiency to justify the cost. Capital One must balance modernization against credit risk and profit pressure. Meta must balance product momentum against depreciation, energy needs and a larger infrastructure base.

The comparison has limits. One company is a regulated lender exposed to consumer credit and funding markets; the other is an advertising platform financing AI from substantial operating cash flow. Their spending should not be valued with the same multiple or risk assumption.

No reported result was available when this preview was prepared. An earnings preview is a map of uncertainties, not a forecast that those uncertainties will resolve favorably.

Investors should use the companies' official releases and calls to check the numbers: credit performance and expense guidance at Capital One, then capital expenditure, operating expenses and evidence of monetization at Meta. The market reaction will likely depend less on headline revenue than on whether management can define the return on investment.

Find us onGoogle News

Latest comments

BT
Community Guidelines
Next Article
stocks 20 / 10 / 2026 Be The Investor Research 2 min read

Bank OZK's Rising Dividend Is Well Covered, but Credit Still Sets the Limit

Share
Bank OZK's Rising Dividend Is Well Covered, but Credit Still Sets the Limit

Bank OZK raised its quarterly dividend for a 65th straight quarter. A payout near one-third of earnings provides room, while construction-loan credit remains the main constraint.

Bank OZK raised its quarterly common dividend to $0.49 on Oct. 1, the 65th consecutive quarterly increase. The new annualized rate is $1.96 per share, and the source calculated a forward yield of about 4.3% at the price then quoted.

The dividend is well covered by recent earnings. Trailing 12-month earnings of $6.06 imply a payout ratio of about 32%. Put differently, the bank retains roughly two-thirds of reported profit for capital, growth and credit losses.

Second-quarter earnings were $1.49 per diluted share, down from $1.58 a year earlier but up from $1.44 in the first quarter. Net income available to common shareholders was $163.3 million. Those figures support the current payment, even without assuming faster profit growth.

Bank OZK is also returning capital through repurchases. It authorized a new $200 million program in June after using most of a previous authorization over the preceding four quarters. Buybacks below tangible book value can increase value per remaining share, but only if the bank's assets and credit reserves are sound.

That qualification matters because Bank OZK has a large commercial real estate and construction-lending franchise. Management said Real Estate Specialties Group repayments approached $10 billion over four quarters, reducing concentration. It expected construction loans to fall below the relevant concentration guideline around year-end or early 2027.

Credit indicators were not uniformly benign. Special-mention loans increased, and the bank charged off $22 million on a Seattle office property. Special mention is not the same as nonperforming, but it identifies loans that require closer monitoring. Management said reserves had been built before the charge-off and warned that additional problem assets could emerge.

The dividend record is therefore supported by arithmetic rather than tradition alone. A payout near one-third of earnings, steady quarterly profitability and retained capital give the board room for small increases.

The limit is credit. If losses in office, life-science or other construction exposures rise faster than allowances, earnings and capital will absorb the damage before the dividend. Investors should watch special-mention balances, charge-offs, reserve coverage and the pace of RESG repayments alongside the next one-cent increase.

Bank OZK is scheduled to report third-quarter results after the market close on Oct. 20. That release will provide fresher evidence than the dividend history about whether the yield remains comfortably funded.

Find us onGoogle News

Latest comments

BT
Community Guidelines